CBD Med Research Corp. (TSXV:CBMH) (the “Company”) announces that the Company will change its name to World Class Extractions Inc. and subdivide its common shares on the basis of three new common shares for every one existing common share (the “Share Split”), effective as of February 28, 2019 (the “Effective Date”).

Registered shareholders of the Company will receive two additional common shares for each common share held as of February 27, 2019 (the “Record Date”).  The Company’s transfer agent, Computershare Investor Services Inc. (“Computershare”), will send to each registered shareholder a share certificate representing the number of additional common shares that they are to receive as a result of the Share Split.  Non-registered shareholders who hold their shares through an intermediary will have their accounts automatically updated to reflect the Share Split.


Immediately prior to completion of the Share Split, the Company has 9,671,525 common shares issued and outstanding.  After giving effect to the Share Split, the Company will have approximately 29,014,575 common shares issued and outstanding.

Further to the Company’s news release dated February 21, 2019, the Company’s common shares will be delisted from trading on the TSX Venture Exchange effective at the close of trading on February 26, 2019 in connection with the proposed reverse take-over transaction of the Company (the “Proposed Transaction”).  The resulting issuer that will exist upon completion of the Proposed Transaction intends to apply to the Canadian Securities Exchange (“CSE”) for approval for listing its common shares on the CSE.

ON BEHALF OF THE BOARD OF DIRECTORS

“Gary F Zak”

Gary F. Zak, Chief Executive Officer

For further information, please contact: Gary F. Zak gzak1@shaw.ca or 604-802-7551

Neither the TSX Venture Exchange nor its Regulation Services Provider (as such term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The CSE has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this news release.

Forward-Looking Statements

This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively “forward-looking statements”). The use of any of the word, “may”, “will”, “proposes”, “expects”, “anticipates”, “intends” and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such forward-looking statements should not be unduly relied upon. This news release contains forward-looking statements and assumptions pertaining to the following: the name change of the Company, the Share Split, delisting the Company’s common shares from the TSXV, listing the Company’s common shares on the CSE, and the Proposed Transaction. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors. The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct.

Source: globenewswire.com

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less